Business
Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products
CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing agreement with Finceramica Faenza S.p.A., an innovative Italian biomaterials company. The three-year extension strengthens the longstanding partnership, granting Kelyniam expanded access to Finceramica's advanced product portfolio, including SINTlife, a next-generation fully resorbable syntheti
About this update from Kelyniam Global, Inc.
[{"type":"image","alt":"Kelyniam Global Inc.","displaySize":"","headline":null,"caption":"Kelyniam Global Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":298,"height":97,"url":"https://media.zenfs.com/en/globenewswire.com/51ed2e4fc73a7399f26e3465f3910bc5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Vkk9ccWjJpcRu6bSeQMEgw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/51ed2e4fc73a7399f26e3465f3910bc5","width":298,"height":97}},"lazy":false},{"type":"text","content":"CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing agreement with Finceramica Faenza S.p.A., an innovative Italian biomaterials company. The three-year extension strengthens the longstanding partnership, granting Kelyniam expanded access to Finceramica's advanced product portfolio, including SINTlife, a next-generation fully resorbable synthetic graft made of substituted magnesium hydroxyapatite nanocrystals, available in injectable putty form, Surgery V-Connect a Smart Augmented Reality System and other products","length":676,"tagName":"p"},{"type":"text","content":"SINTlife product is expected to receive FDA clearance within 2 years, targeting markets estimated to be 10 times larger than the current custom cranial implant sector.","length":167,"tagName":"p"},{"type":"text","content":"This renewal not only secures Kelyniam's position as a key U.S. distributor but also positions the company for significant expansion into high-growth areas of regenerative medicine. By leveraging Finceramica's proprietary technologies, Kelyniam aims to diversify its offerings beyond its patented cranial implants, addressing broader needs in orthopedic and reconstructive surgery.","length":389,"tagName":"p"},{"type":"text","content":""We are thrilled to extend our collaboration with Finceramica, a partnership that has already delivered innovative solutions for patients undergoing cranial reconstruction," said Ross Bjella, CEO of Kelyniam Global. "This renewal provides us with exclusive access to groundbreaking biomaterials like SINTlife, which will open doors to expansive markets in bone regeneration. We're excited about the mutual benefits—Fincer...